The movement protein (MP) of tomato mosaic virus (ToMV) was produced in E. coli as a soluble fusion protein with glutathione S-transferase. When immobilized on glutathione affinity beads, the recombinant protein was phosphorylated in vitro by incubating with cell extracts of Nicotiana tabacum and tobacco suspension culture cells (BY-2) in the presence of [γ- 
Introduction
The movement proteins (MPs) encoded by plant viruses have been shown to be essential for cell-to-cell movement through intercellular connections called plasmodesmata (Deom et al., 1987 (Deom et al., , 1992 Meshi et al., 1987 Meshi et al., , 1992 Lucas & Gilbertson, 1994 ; Carrington et al., 1996) . MPs are also known to have nonspecific single-stranded nucleic acid-binding activity, suggesting the ability of MPs to bind to and aid in transport of the viral RNA from cell to cell (Citovsky et al., 1990 ; Li & Palukaitis, 1996 ; Fujita et al., 1998) . In the case of tobamoviruses such as tobacco mosaic virus (TMV) and tomato mosaic virus (ToMV), MPs are known to be synthesized in the early stages of infection (Watanabe et al., 1984) and to be localized in plasmodesmata (Tomenius et al., 1987 ; . MPs are also reported to be involved in host Author for correspondence : Hiroshi Nyunoya.
Fax j81 42 367 5563. e-mail nyunoya!cc.tuat.ac.jp specificity, suggesting interactions between MPs and host-cell factors (Taliansky et al., 1982 ; Atabekov & Dorokhov, 1984 ; Meshi et al., 1989 ; Mise et al., 1993 ; Weber et al., 1993 ; Fenczik et al., 1995 ; Weber & Pfitzner, 1998 ; Reichel et al., 1999) .
Phosphorylation of TMV MP has been examined by several groups. showed that plantexpressed TMV MP comigrates during SDS-PAGE with the phosphorylated form of a recombinant MP prepared from insect cells infected with baculovirus. Direct evidence for in vivo phosphorylation was obtained by using TMV RNAinoculated protoplasts Haley et al., 1995) or MP-expressing transgenic plants (Citovsky et al., 1993) . These groups have identified possible phosphorylation sites in several regions including the serine-rich C-terminal peptide. For example, Citovsky et al. (1993) have demonstrated phosphorylation of serine-258, threonine-261 and serine-265 of TMV MP by a cell wall-associated protein kinase. Kawakami et al. (1999) identified serine-37 and serine-238 as the sites of phosphorylation in vivo and suggested that the presence and state of phosphorylation of serine-37 in MPs is important for cell-to-cell movement of the virus genome.
The protein kinases that phosphorylate MPs have not yet been firmly identified although there are reports on the possible involvement of cyclic AMP-dependent kinase (Atabekov & Taliansky, 1990 ) and cell wall-associated protein kinase (Citovsky et al., 1993) . Since protein kinases are not encoded by plant viruses (Goelet et al., 1982 ; Ohno et al., 1984) , candidate kinases may be considered as host factors interacting with MP. As a first step to characterize such hostplant kinases, we prepared a recombinant MP and established a protein-complex kinase assay system.
Methods
Plasmid construction. The 1n0 kb MaeI fragment of plasmid pLQV5 (Meshi et al., 1992) , containing the coding sequence for the MP of ToMV (formerly designated TMV tomato strain L), was treated with Klenow fragment to fill in the 3h termini and inserted into the SmaI site of pBluescriptII SK(j) (Stratagene) to create pBS-30K, with the coding sequence in the EcoRI to NotI sense of the vector. The 1n0 kb EcoRI-NotI fragment was subsequently inserted into the EcoRI-NotI sites of pGEX-5X-2 (Amersham Pharmacia) to produce pGEX-30K, which encodes glutathione S-transferase (GST)-fused ToMV MP.
The 1n0 kb MaeI fragments of plasmids pTLW3 and pTLQ37A238A (Kawakami et al., 1999) , containing the coding sequence for wild-type and mutant ToMV MPs, respectively, were treated with Klenow fragment to fill in the 3h termini and inserted into the SmaI site of pGEX-6P-3 (Amersham Pharmacia) to create pGEX-30KSS and pGEX-30KS37AS238A, respectively. Both vectors contain the coding sequences in the EcoRI to NotI sense of the vector. pGEX-30KSS encodes GST-fused wild-type MP while pGEX-30KS37AS238A encodes GST-fused mutant MP with alanine residues substituted for serine-37 and serine-238.
For construction of the plasmids encoding GST-fused ToMV MPs with C-terminal truncations, plasmid pGEX-30K was digested with AatII alone or StuI plus XbaI to remove the 0n54 kb AatII or 0n31 kb StuI-XbaI fragments, respectively. The remaining larger DNA fragments were treated with Klenow fragment before self-ligation to create plasmids pGEX-30KdA and pGEX-30KdSX.
Production of recombinant protein. Recombinant proteins were produced in E. coli strain XL-1 Blue (Stratagene) transformed with the various plasmids constructed for expression of GST fusion proteins. The names of the plasmids and corresponding recombinant proteins were as follows : pGEX-5X-2 for GST ; pGEX-30K for GST-MP ; pGEX-30KSS for GST-MPSS ; pGEX-30KS37AS238A for GST-MPAA ; pGEX-30KdA for GST-MPdA ; pGEX-30KdSX for GST-MPdSX. The recombinant protein GST-MPdA had the C-terminal 9 amino acids replaced by 27 nonviral residues (QVALFGEMCAEPLFVYFSKYIQICIRS) derived from the vector. Another recombinant protein, GST-MPdSX, had the Cterminal 31 amino acids replaced by 7 residues (LERPHRD) derived from the vector. Protein expression was induced by addition of 0n2 mM IPTG. The recombinant proteins were purified using glutathione-Sepharose 4B beads (Amersham Pharmacia) as described by Kaelin et al. (1991) and stored in a modified NETN buffer (50 mM Tris-HCl, pH 8n0, 1 mM EDTA, 150 mM NaCl, 0n5 % Nonidet P-40) supplemented with 1 mM dithiothreitol (DTT).
Preparation of plant-cell extracts. Seeds of Nicotiana tabacum L. cv. Samsun NN were germinated and grown under a light (16 h)\dark (8 h) cycle at 24 mC. Suspension cultures of a BY-2 tobacco cell line were maintained as described by Nagata et al. (1981) and cells in the lateexponential phase were frozen at k80 mC after washing with PBS (137 mM NaCl, 2n68 mM KCl, 10n1 mM Na # HPO % , 1n76 mM KH # PO % , pH 7n4). To prepare the cell extracts, leaves (0n1 g fresh wt\ml) of the tobacco plants and frozen BY-2 cells (0n4 g fresh wt\ml) were suspended in PBS supplemented with 1 mM DTT and 1 mM PMSF, homogenized using a Polytron (PT3000 ; Kinematica) and then disrupted by sonication. After centrifugation for 20 min at 16 000 g, the supernatant was diluted with PBS to adjust the protein concentration to 1 mg\ml for use in the kinase assay.
Kinase assay. For the simple kinase assay, glutathione-Sepharose 4B beads conjugated to 1 µg of recombinant protein were suspended in 100 µl of kinase buffer (40 mM HEPES, pH 7n4, 10 mM MgCl # , 3 mM MnCl # ) including 45 µl cell extract as prepared above plus the protease inhibitors pepstatin A (1 µg\ml), aprotinin (2 µg\ml), chymostatin (0n1 µg\ml), leupeptin (0n5 µg\ml) and trans-epoxysuccinyl--leucylamido-[4-guanidino]butane (7n2 µg\ml). The phosphorylation assay was started by addition of 370 kBq [γ-$#P]ATP (168 TBq\mmol), incubated for 30 min at 25 mC on a rotator, and terminated by washing the beads twice with 0n9 ml NETN buffer.
For the protein-complex kinase assay, glutathione-Sepharose beads conjugated to 1 µg recombinant protein were incubated in 1 ml PBS containing a 45 µl aliquot of plant-cell extract and protease inhibitors for 1 h at 4 mC on a rotator. The beads thus treated were washed twice with 1 ml of NETN buffer, twice with 1 ml of kinase buffer and resuspended in 100 µl of kinase buffer. The phosphorylation assay was performed with [γ-$#P]ATP under the same conditions as the simple kinase assay, except that no additional cell extract and protease inhibitors were added. For pull-down experiments, diluted plant extracts were preincubated with appropriate beads before protein-complex formation with GST-MP. Protein phosphorylation was analysed by SDS-PAGE followed by image analysis with a BAS-1500 system (Fuji Photo Film).
Phosphoamino acid analysis.
Proteins phosphorylated with [γ-$#P]ATP were separated by SDS-PAGE and blotted onto PVDF membrane. The protein band was excised and hydrolysed for 2 h at 110 mC in 6 M HCl. The phosphoamino acids were analysed as described by Kamps & Sefton (1989) using the BAS-1500 system.
Results

Expression of recombinant MP
E. coli transformants containing the expression plasmid pGEX-30K or the control vector plasmid pGEX-5X-2 were induced with IPTG and the recombinant proteins were affinitypurified on a glutathione-Sepharose column. The identity of the recombinant 56 kDa MP protein (GST-MP) was confirmed by Western blot analysis using anti-GST (Amersham Pharmacia) and anti-MP antibodies (Meshi et al., 1992) with GST and histidine-tagged recombinant MP from pLQV5 plasmid (Meshi et al., 1992) serving as negative and positive controls, respectively (data not shown). GST-MP was mostly soluble and was used in an RNA-binding assay on nitrocellulose membrane. GST-MP and single-stranded DNA binding protein used as a positive control showed dosedependent RNA-binding activity, while GST and BSA used as negative controls showed no such activity (data not shown).
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Protein kinase complex with ToMV MP Protein kinase complex with ToMV MP Fig. 1 . Protein-complex kinase assay with GST-MP. Aliquots of glutathione-Sepharose beads conjugated with GST (lanes 1-3) or GST-MP (lanes 4-6) were incubated with PBS (lanes 1 and 4), an extract of tobacco leaves (lanes 2 and 5) or BY-2 cells (lanes 3 and 6) and used for phosphorylation reactions after washing the beads with NETN buffer. The reaction products were subjected to SDS-PAGE through a 10 % gel and visualized by Coomassie blue staining (a). The same gel was analysed by autoradiography (b). Arrows indicate the positions of the protein bands corresponding to GST and GST-MP. Positions of molecular mass (kDa) markers are shown on the left. 
Protein-complex kinase assay with plant extracts
Preliminary experiments showed that GST-MP immobilized on glutathione-Sepharose beads was phosphorylated in vitro by protein kinase activities in the crude extracts of leaves of N. tabacum and BY-2 cells. To avoid effects of proteases and protein phosphatases possibly present in the plant cell extract at 4 mC, GST-MP could form a stable protein complex with a protein kinase or kinases in the extract. As shown in Fig. 1 , GST-MP was phosphorylated by such a kinase activity present in both the cell extracts from tobacco leaves (lane 5) and BY-2 (lane 6), while GST was not phosphorylated by either cell extract (lanes 2 and 3). As shown in Fig. 2 , phosphorylation of GST-MP was observed even after washing the beads with NETN buffer containing 3n0 M NaCl.
To exclude the possibility that the kinase in the cell extracts formed a complex with the GST moiety of the recombinant protein, a pull-down experiment was carried out. As shown in Fig. 3 , the cell extracts were preincubated with the beads conjugated with no protein (lane 2), with GST (lane 3) or with GST-MP (lane 4) before incubation for the protein-complex kinase assay. Preincubation of the cell extracts with GST-MP beads (lane 4) resulted in a decrease in phosphorylation of GST-MP in the assay, while preincubation with beads alone (lane 2) or GST beads (lane 3) had no effect on the phosphorylation compared to a control subjected to no preincubation (lane 1). The result indicates that the kinase in the cell extracts was pulled down by GST-MP beads through interaction with the MP moiety of GST-MP during the preincubation.
Characterization of the protein kinase
To determine the type of protein kinase responsible for the phosphorylation of GST-MP, we examined the effects of various protein kinase inhibitors. By using the protein-complex kinase assay, we found that addition of heparin, suramin or quercetin effectively inhibited phosphorylation (Fig. 4 a-c) at concentrations at which these inhibitors are known to inhibit CK II (Hathaway et al., 1980 ; Aboagye-Kwarteng et al., 1991 ; Ruzzene et al., 1992) . In contrast, there was no effect on the phosphorylation with other inhibitors such as GF109203X, H-89, KN-62 and genistein, which are known to inhibit protein kinase C, protein kinase A, Ca# + \calmodulin-dependent protein kinase II and tyrosine protein kinase, respectively (Fig.  4 d-g ).
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Protein kinase complex with ToMV MP Protein kinase complex with ToMV MP Utilization of both GTP and ATP as phosphoryl donor is known to be a unique feature of CK II (Hathaway & Traugh, 1983) . As shown in Fig. 5 (a) , incorporation of $#P to MP in the protein-complex kinase assay was diminished in a dosedependent manner by the addition of unlabelled GTP, suggesting that utilization of ATP was competitively inhibited by GTP. Direct evidence for utilization of GTP was provided by incorporation of $#P to MP in the same assay system but with [γ-$#P]GTP as source, a reaction which was also sensitive to heparin (Fig. 5 b) . Kawakami et al. (1999) reported that in vivo phosphorylation of ToMV MP required serine residues at 37 and 238. Because these residues are in a consensus motif for phosphorylation by CK II, we expressed recombinant MP (GST-MPAA) with alanine residues substituted for serine-37 and serine-238 and tested phosphorylation in our proteincomplex kinase assay. As shown in Fig. 6 (a) , there was no difference in protein phosphorylation levels between the wildtype (GST-MPSS) and the mutant (GST-MPAA).
Phosphorylation of mutant MPs
Phosphoamino acids were analysed with acid hydrolysate of GST-MPSS and GST-MPAA that had been phosphorylated with [γ-$#P]ATP in the protein-complex kinase assay (Fig.  6 b) . Autoradiography after thin-layer electrophoresis indicated that $#P was incorporated into spots corresponding to phosphoserine and phosphothreonine but not phosphotyrosine, which suggests the involvement of a serine\ threonine protein kinase.
We next tried to locate the region of phosphorylation by creating truncated recombinant MPs with deletions in the serine-rich C-terminal region. As shown in Fig. 7 , phosphorylation was almost completely inhibited for GSTMPdA and GST-MPdSX, in which 9 and 31 amino acids, respectively, were removed from the C termini. This result CAJJ Y. Matsushita and others Y. Matsushita and others suggests that the phosphorylation sites are located within the C-terminal 9 amino acids, although we cannot strictly rule out the possibility that these deletions and\or the extra nonviral residues appended to the C terminus caused conformational changes of the recombinant protein leading to loss of affinity to the protein kinase. Kawakami et al. (1999) carried out in vivo phosphorylation analyses and created a series of mutant ToMV MPs by introducing single or double amino acid replacements. The mutant viral RNAs were inoculated into BY-2 protoplasts to detect $#P-labelled ToMV MP. By comparing $#P incorporation between the wild-type and mutant MPs, they established that serine-37 and serine-238 were the amino acid residues phosphorylated in vivo. Further experiments illustrated an essential role for serine-37 in the function and stability of ToMV MP. It has been reported that CK II of animals and yeast phosphorylates serine and threonine residues within the consensus motif (S\T)XX(D\E) (Pearson & Kemp, 1991) . In ToMV MP, there are seven serine\threonine residues placed in such a context, including serine-37 (SKVD) and serine-238 (SFDE) which were phosphorylated as described above.
Discussion
To characterize the cellular kinases responsible for phosphorylation of ToMV MP we took advantage of an in vitro assay system using recombinant MP as a substrate, so that effects of kinase inhibitors and enzyme-substrate interactions could be assessed directly. The protein-complex kinase assay system employed in this study allowed us to eliminate the effects of various cellular factors such as proteases, phosphatases and other kinases that did not associate with the substrate. The kinase associated with ToMV MP was shown to be inhibited by heparin, suramin and quercetin at concentrations that are reported to inhibit CK II. In contrast, the kinase activity was not affected by other types of protein kinase inhibitor. Atabekov & Taliansky (1990) suggested the possible involvement of cyclic AMP-dependent protein kinase in the phosphorylation of TMV MP. In our in vitro assay system, however, addition of an inhibitor for protein kinase A (H-89) did not affect phosphorylation of GST-MP by BY-2 cell extract. In addition, GST-MP could not serve as a substrate for the catalytic subunit of murine protein kinase A in our simple kinase assay (data not shown). Although protein kinase A has not been reported in higher plants, our results suggest that such an enzyme, if it exists in plants, does not participate directly in the phosphorylation of ToMV MP.
In contrast to the in vivo phosphorylation data (Kawakami et al., 1999) , the phosphoamino acid analysis reported here indicated that both serine and threonine residues were phosphorylated in the protein-complex kinase assay. Furthermore, the levels of phosphorylation at serine and threonine residues of the mutant GST-MPAA were comparable to the wild-type. These results suggest that some mechanism may exist whereby the in vivo phosphorylation status of MP is strictly controlled. Perhaps the structure of MP may be sensitive in vivo to some protein modification other than phosphorylation, which results in steric hindrance and inaccessibility to the cellular protein kinases. It is also possible that the CK II-like protein kinase activity detected in our study may be different from the one responsible for the phosphorylation of serine-37 and\or serine-238 (Kawakami et al., 1999) . However, our in vitro study, focusing on the particular kinase that formed a stable complex with the substrate, need not necessarily be in contradiction with the results of the in vivo study, which could reflect a steady-state level of phosphorylation of the substrate as it is interacting with various cellular factors such as phosphatases and possible endogenous kinase inhibitors. Perhaps multiple protein kinases distributed in different cellular compartments may participate in the phosphorylation of ToMV MP. In fact, our simple kinase assay with cellular extracts resulted in a significant level of phosphorylation of GST-MP that could not be diminished by the CK II inhibitors (data not shown). Citovsky et al. (1993) have detected a cell wall-associated protein kinase involved in the phosphorylation of serine-258, threonine-261 and serine-265 of TMV MP. Although the MP of this TMV strain has a somewhat different C-terminal sequence from that of ToMV, threonine-261 and serine-265 of TMV MP may correspond to serine-257 and serine-261 of CBAA Protein kinase complex with ToMV MP Protein kinase complex with ToMV MP Fig. 8 . C-terminal serine/threonine clusters in MPs of two viruses. A part of the amino acid sequence of ToMV MP (Ohno et al., 1984) and of TMV MP (Goelet et al., 1982) ToMV MP, respectively (Fig. 8) . Our in vitro assay using the Cterminally truncated GST-MPs indicated that deletions of these residues (in addition to threonine-256 of ToMV MP) resulted in almost complete loss of phosphorylation. Since the kinase assay is dependent on complex formation between GST-MP and cellular protein(s), the loss of phosphorylation may be attributable either to the absence of the target residues for the protein kinase or failure of the complex to form due to a conformational change in the substrate. In either case, it should be noted that we used a buffer without any detergents to prepare cell extracts, which hence should contain only soluble material and may not contain cell-wall associated proteins. According to Citovsky et al. (1993) , the cell wallassociated kinase was absent from the soluble fraction. Thus, the CK II-like protein kinase in our study would be distinct from the cell wall-associated kinase reported by Citovsky et al. (1993) . Padgett et al. (1996) reported a dynamic aspect of the cellular distribution of MP, which varied spatiotemporally from the early to the late stages of infection. MP probably interacts with various cellular components to manifest its multiple functions at various subcellular locations including the cortical ER, microtubules and plasmodesmata. Thus there may be several protein kinases that can phosphorylate MP so as to regulate its interaction with various cellular proteins. It is not known whether the CK II-like protein kinase described here binds directly to MP or associates with MP through a tethering protein. Further work will be required for the determination of the specific phosphorylation sites and the identification of the protein kinase, information which should help understand the significance of the complex formation between the protein kinase and MP in infected cells.
